KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Other financing activities (2017 - 2025)

Johnson & Johnson (JNJ) has disclosed Other financing activities for 12 consecutive years, with -$26.0 million as the latest value for Q4 2025.

  • Quarterly Other financing activities changed N/A to -$26.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$34.0 million through Dec 2025, up 10.53% year-over-year, with the annual reading at -$34.0 million for FY2025, 10.53% up from the prior year.
  • Other financing activities hit -$26.0 million in Q4 2025 for Johnson & Johnson, up from -$49.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $275.0 million in Q1 2021 to a low of -$384.0 million in Q4 2023.
  • Historically, Other financing activities has averaged -$6.5 million across 5 years, with a median of -$8.0 million in 2023.
  • Biggest five-year swings in Other financing activities: surged 238.96% in 2021 and later crashed 4700.0% in 2023.
  • Year by year, Other financing activities stood at $18.0 million in 2021, then tumbled by 866.67% to -$138.0 million in 2022, then tumbled by 178.26% to -$384.0 million in 2023, then skyrocketed by 80.47% to -$75.0 million in 2024, then skyrocketed by 65.33% to -$26.0 million in 2025.
  • Business Quant data shows Other financing activities for JNJ at -$26.0 million in Q4 2025, -$49.0 million in Q3 2025, and $1.0 million in Q2 2025.